Literature DB >> 16738848

Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model.

Reeta L Veteläinen1, Roelof J Bennink, Kora de Bruin, Arlène van Vliet, Thomas M van Gulik.   

Abstract

PURPOSE: This study evaluated the utility of non-invasive assessment of hepatobiliary function by 99mTc-mebrofenin cholescintigraphy in a rat model of diet-induced steatosis.
METHODS: Male Wistar rats (250-300 g) were fed a standard methionine- and choline-deficient (MCD) diet for up to 5 weeks, thereby inducing hepatic fat accumulation, progressive inflammation and fibrogenesis corresponding with clinical steatosis. 99mTc-mebrofenin pinhole scintigraphy was used to evaluate the hepatocyte mebrofenin uptake rate, the time of maximum hepatic uptake (T(peak)) and the time required for peak activity to decrease by 50% (T(1/2peak)). Scintigraphic parameters were correlated with biochemical and serological parameters and with liver histopathology.
RESULTS: MCD diet induced mild steatosis after 1 week and severe steatosis with prominent inflammation after 5 weeks. T(peak), T(1/2peak) prolonged and the uptake rate decreased significantly, while the severity of steatosis increased (p<0.05). There was a strong, significant correlation between the severity of steatosis (histopathology, hepatic triglyceride content) and the 99mTc-mebrofenin uptake rate (r2=0.83, p<0.0001 and r2=0.82, p<0.0001, respectively). In addition, the uptake rate correlated significantly with the increased inflammation (plasma and hepatic TNF-alpha, r2=0.72, p<0.0001 and r2=0.52, p=0.001, respectively). The correlation of the uptake rate with hepatocellular damage was weak (AST and ALT, r2=0.29 and 0.32, respectively), but correlation with synthetic function was strong (prothrombin time, r2=0.70, p<0.001).
CONCLUSION: Hepatobiliary function assessed by 99mTc-mebrofenin scintigraphy correlates with the extent and progression of steatosis. These results suggest a potential role for mebrofenin scintigraphy as a non-invasive functional follow-up method for disease progression in steatotic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738848     DOI: 10.1007/s00259-006-0125-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  29 in total

1.  Blood clearance of 99mTc-trimethyl-Br-IDA discriminates between different degrees of severe liver ischaemia--reperfusion injury in the rat.

Authors:  R Chavez-Cartaya; P Ramirez; T Fuente; G P DeSola; J Marin; A Piñero; P Parrilla; N V Jamieson
Journal:  Eur Surg Res       Date:  1997       Impact factor: 1.745

2.  Imaging of liver function with dedicated animal dynamic pinhole scintigraphy in rats.

Authors:  Roelof J Bennink; Reeta Vetelainen; Kora de Bruin; Arlène K van Vliet; Thomas M van Gulik
Journal:  Nucl Med Commun       Date:  2005-11       Impact factor: 1.690

Review 3.  Hepatobiliary transport: molecular mechanisms of development and cholestasis.

Authors:  M Arrese; M Ananthananarayanan; F J Suchy
Journal:  Pediatr Res       Date:  1998-08       Impact factor: 3.756

Review 4.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

5.  Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.

Authors:  Deha Erdogan; Bob H M Heijnen; Roelof J Bennink; Mariël Kok; Sander Dinant; Irene H Straatsburg; Dirk J Gouma; Thomas M van Gulik
Journal:  Liver Int       Date:  2004-04       Impact factor: 5.828

6.  In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.

Authors:  N Harry Hendrikse; Folkert Kuipers; Coby Meijer; Rick Havinga; Charles M A Bijleveld; Winette T A van der Graaf; Willem Vaalburg; Elisabeth G E de Vries
Journal:  Cancer Chemother Pharmacol       Date:  2004-04-30       Impact factor: 3.333

7.  Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid.

Authors:  M D Loberg; M Cooper; E Harvey; P Callery; W Faith
Journal:  J Nucl Med       Date:  1976-07       Impact factor: 10.057

8.  Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy.

Authors:  Roelof J Bennink; Sander Dinant; Deha Erdogan; Bob H Heijnen; Irene H Straatsburg; Arlene K van Vliet; Thomas M van Gulik
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

9.  Kupffer cell and hepatocyte function in rat transplanted liver.

Authors:  G Svensson; M Fjälling; J Gretarsdottir; L Jacobsson; S B Holmberg
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

10.  Hepatic extraction efficiency of technetium-99m-mebrofenin in the dog with toxic-induced acute liver disease.

Authors:  G B Daniel; R C DeNovo; A E Schultze; D Schmidt; G T Smith
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

View more
  9 in total

1.  Cholescintigraphic measurement of liver function: how is it different from other methods?

Authors:  Gerbail T Krishnamurthy; Shakuntala Krishnamurthy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10       Impact factor: 9.236

2.  Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.

Authors:  Céline Giraudeau; Benjamin Leporq; Sabrina Doblas; Matthieu Lagadec; Catherine M Pastor; Jean-Luc Daire; Bernard E Van Beers
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

3.  Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin.

Authors:  Brigid Joseph; Kuldeep K Bhargava; Gene G Tronco; Christopher J Palestro; Sanjeev Gupta
Journal:  Nucl Med Commun       Date:  2008-04       Impact factor: 1.690

4.  Potential of (99m)Tc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice.

Authors:  Takemi Rokugawa; Tomoya Uehara; Yusuke Higaki; Shuuichi Matsushima; Atsushi Obata; Yasushi Arano; Kohji Abe
Journal:  EJNMMI Res       Date:  2014-10-09       Impact factor: 3.138

5.  Antioxidative Effects of Curcumin on the Hepatotoxicity Induced by Ochratoxin A in Rats.

Authors:  Sara Damiano; Consiglia Longobardi; Emanuela Andretta; Francesco Prisco; Giuseppe Piegari; Caterina Squillacioti; Serena Montagnaro; Francesco Pagnini; Paola Badino; Salvatore Florio; Roberto Ciarcia
Journal:  Antioxidants (Basel)       Date:  2021-01-17

6.  Eugenol Administration Improves Liver Damage Induced by a Fructose-Rich Diet.

Authors:  Abbass Ali Niazi; Fatemeh Kourkinejad Gharaei; Zahra Saebinasab; Maryam Maleki; Fatemeh Maghool; Fatemeh Fereidooni; Tahereh Safari
Journal:  Adv Biomed Res       Date:  2021-11-26

7.  In-vitro and in-vivo functional observation studies to establish therapeutic potential of alpha-ketoglutarate against methotrexate induced liver injury.

Authors:  Lalita Mehra; Aditi Bhattacharya; Harish Rawat; Amit Kumar; Abhinav Jaimini; Gaurav Mittal
Journal:  Biomed J       Date:  2020-05-23       Impact factor: 4.910

8.  Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators.

Authors:  Mohamed E Shaker; Mohamed F Hamed; Ahmed A Shaaban
Journal:  Saudi Pharm J       Date:  2022-01-19       Impact factor: 4.562

9.  A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence.

Authors:  Martin Voss; Sandra Pinkert; Meike Kespohl; Niclas Gimber; Karin Klingel; Jan Schmoranzer; Michael Laue; Matthias Gaida; Peter-Michael Kloetzel; Antje Beling
Journal:  Viruses       Date:  2022-04-07       Impact factor: 5.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.